Pharmacogenomic curriculum in Australian medical schools: a content analysis study.

IF 1.9 4区医学 Q3 PHARMACOLOGY & PHARMACY

Pharmacogenomics Pub Date : 2025-01-17 DOI:10.1080/14622416.2025.2452834

Jade Thomas, Faith R Yong, Natalia Kryzyaniak, Christy Noble, Christopher R Freeman

{"title":"Pharmacogenomic curriculum in Australian medical schools: a content analysis study.","authors":"Jade Thomas, Faith R Yong, Natalia Kryzyaniak, Christy Noble, Christopher R Freeman","doi":"10.1080/14622416.2025.2452834","DOIUrl":null,"url":null,"abstract":"Aims: To ascertain and describe pharmacogenomic concepts included in the intended curriculum of accredited Australian medical schools.Methods: Content analysis of curriculum learning objectives of Australian medical schools was conducted, focusing on keywords and phrases pertaining to pharmacogenomic education. Learning objectives related to pharmacogenomics were categorized using (1) undergraduate medical genomic competencies per the Association of Professors in Human and Medical Genetics (2) Bloom's Taxonomy for cognitive and knowledge dimensions and (3) knowledge translation (enabling science, translation science and clinical implementation).Results: The curricula of 19 accredited medical schools in Australia were analyzed. Two-thirds (68%) contained genomic/pharmacogenomic education. Eight schools had content relating to undergraduate medical genomic competencies. Of those which had pharmacogenomic-related learning objectives, the majority (65%) were categorized in Bloom's Taxonomy's lower levels (Remember and Understand) and 15% were deemed to be at the level of 'Clinical Implementation.'Conclusion: The majority of Australian medical schools have incorporated pharmacogenomics in their current curriculum; however, learning objectives addressing application and clinical implementation are required. Doctors have a unique role to play in implementing pharmacogenomics into clinical practice. Comprehensiveness of course curricula across all learning domains would support uptake of pharmacogenomics into routine practice.","PeriodicalId":20018,"journal":{"name":"Pharmacogenomics","volume":" ","pages":"1-9"},"PeriodicalIF":1.9000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14622416.2025.2452834","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

Aims: To ascertain and describe pharmacogenomic concepts included in the intended curriculum of accredited Australian medical schools.

Methods: Content analysis of curriculum learning objectives of Australian medical schools was conducted, focusing on keywords and phrases pertaining to pharmacogenomic education. Learning objectives related to pharmacogenomics were categorized using (1) undergraduate medical genomic competencies per the Association of Professors in Human and Medical Genetics (2) Bloom's Taxonomy for cognitive and knowledge dimensions and (3) knowledge translation (enabling science, translation science and clinical implementation).

Results: The curricula of 19 accredited medical schools in Australia were analyzed. Two-thirds (68%) contained genomic/pharmacogenomic education. Eight schools had content relating to undergraduate medical genomic competencies. Of those which had pharmacogenomic-related learning objectives, the majority (65%) were categorized in Bloom's Taxonomy's lower levels (Remember and Understand) and 15% were deemed to be at the level of 'Clinical Implementation.'

Conclusion: The majority of Australian medical schools have incorporated pharmacogenomics in their current curriculum; however, learning objectives addressing application and clinical implementation are required. Doctors have a unique role to play in implementing pharmacogenomics into clinical practice. Comprehensiveness of course curricula across all learning domains would support uptake of pharmacogenomics into routine practice.

查看原文本刊更多论文

澳大利亚医学院药物基因组学课程：内容分析研究。

目的：确定和描述药物基因组学概念，包括在经认可的澳大利亚医学院的预定课程中。方法：对澳大利亚医学院课程学习目标进行内容分析，重点分析与药物基因组学教育相关的关键词和短语。与药物基因组学相关的学习目标使用以下方法进行分类：(1)根据人类和医学遗传学教授协会的本科医学基因组学能力；(2)布鲁姆的认知和知识维度分类；(3)知识翻译（使能科学、翻译科学和临床实施）。结果：对澳大利亚19所医学院校的课程进行了分析。三分之二（68%）包含基因组学/药物基因组学教育。八所学校有与本科医学基因组能力相关的内容。在那些与药物基因组学相关的学习目标中，大多数（65%）被归类为布鲁姆分类法的较低水平（记住和理解），15%被认为处于“临床实施”水平。结论：大多数澳大利亚医学院已将药物基因组学纳入其当前课程；然而，学习目标解决应用和临床实施是必要的。医生在将药物基因组学应用于临床实践中发挥着独特的作用。跨所有学习领域的综合性课程将支持将药物基因组学纳入日常实践。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacogenomics 医学-药学

CiteScore

3.40

自引率

9.50%

发文量

审稿时长

4-8 weeks

期刊介绍： Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.